Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Peter Vickerman

Showing results (61-70 of 397) with videos related to

Pageof 40
Sort By:
Sexually Transmitted Diseases|June 1, 2006
Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South AfricaPeter Vickerman, Fern Terris-Prestholt, Sinead Delany, et al.
Plos One|September 30, 2014
Antiretroviral therapy uptake, attrition, adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysisElisa Mountain, Sharmistha Mishra, Peter Vickerman, et al.
The International Journal on Drug Policy|August 28, 2021
Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infectionAndreea Adelina Artenie, Matthew Hickman, Peter Vickerman, et al.
Plos Medicine|October 19, 2021
Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysisAaron G Lim, Nick Scott, Josephine G Walker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 7, 2020
Cost-Effectiveness of HIV Pre-exposure Prophylaxis Among Heterosexual Men in South Africa: A Cost-Utility Modeling AnalysisMichelle Vogelzang, Fern Terris-Prestholt, Peter Vickerman, et al.
BMJ Open|February 10, 2026
Differences in sexual risk behaviours, HIV care utilisation and experiences of stigma between transgender women and cisgender men who have sex with men: findings from integrated biobehavioural surveys in Ukraine 2013-2018Saher Aijaz, Peter Vickerman, Tetiana Saliuk, et al.
AIDS (London, England)|September 16, 2015
Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North AfricaGhina R Mumtaz, Helen A Weiss, Peter Vickerman, et al.
BMJ Open|August 15, 2013
Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisonsNatasha K Martin, Matthew Hickman, Alec Miners, et al.
Plos Medicine|June 25, 2024
Correction: Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysisAaron G Lim, Nick Scott, Josephine G Walker, et al.
Plos One|June 21, 2014
The cost of providing combined prevention and treatment services, including ART, to female sex workers in Burkina FasoFiona Cianci, Sedona Sweeney, Issouf Konate, et al.
Pageof 40

Showing results (61-70 of 397) with videos related to

Sort By:
Pageof 40
Sexually Transmitted Diseases|June 1, 2006
Are targeted HIV prevention activities cost-effective in high prevalence settings? Results from a sexually transmitted infection treatment project for sex workers in Johannesburg, South AfricaPeter Vickerman, Fern Terris-Prestholt, Sinead Delany, et al.
Plos One|September 30, 2014
Antiretroviral therapy uptake, attrition, adherence and outcomes among HIV-infected female sex workers: a systematic review and meta-analysisElisa Mountain, Sharmistha Mishra, Peter Vickerman, et al.
The International Journal on Drug Policy|August 28, 2021
Diversity of incarceration patterns among people who inject drugs and the association with incident hepatitis C virus infectionAndreea Adelina Artenie, Matthew Hickman, Peter Vickerman, et al.
Plos Medicine|October 19, 2021
Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysisAaron G Lim, Nick Scott, Josephine G Walker, et al.
Journal of Acquired Immune Deficiency Syndromes (1999)|March 7, 2020
Cost-Effectiveness of HIV Pre-exposure Prophylaxis Among Heterosexual Men in South Africa: A Cost-Utility Modeling AnalysisMichelle Vogelzang, Fern Terris-Prestholt, Peter Vickerman, et al.
BMJ Open|February 10, 2026
Differences in sexual risk behaviours, HIV care utilisation and experiences of stigma between transgender women and cisgender men who have sex with men: findings from integrated biobehavioural surveys in Ukraine 2013-2018Saher Aijaz, Peter Vickerman, Tetiana Saliuk, et al.
AIDS (London, England)|September 16, 2015
Using hepatitis C prevalence to estimate HIV epidemic potential among people who inject drugs in the Middle East and North AfricaGhina R Mumtaz, Helen A Weiss, Peter Vickerman, et al.
BMJ Open|August 15, 2013
Cost-effectiveness of HCV case-finding for people who inject drugs via dried blood spot testing in specialist addiction services and prisonsNatasha K Martin, Matthew Hickman, Alec Miners, et al.
Plos Medicine|June 25, 2024
Correction: Health and economic benefits of achieving hepatitis C virus elimination in Pakistan: A modelling study and economic analysisAaron G Lim, Nick Scott, Josephine G Walker, et al.
Plos One|June 21, 2014
The cost of providing combined prevention and treatment services, including ART, to female sex workers in Burkina FasoFiona Cianci, Sedona Sweeney, Issouf Konate, et al.
Pageof 40